Navigation Links
Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease

ROCKVILLE, Md., Oct. 15 /PRNewswire-USNewswire/ -- Patients with mid-range coronary artery disease are more likely to get relief from painful angina and less likely to have repeat procedures if they get bypass surgery rather than balloon angioplasty with or without a stent, according to a new report by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

The analysis drew on 23 randomized controlled trials that compared treatments for patients with mid-range coronary disease treatable with either angioplasty or bypass surgery. As defined by the report, mid-range disease may occur in three ways: a single blockage of the vital left anterior descending artery, blockage of two arteries, or some forms of less-severe blockage of three arteries.

The report also found that for mid-range coronary artery disease, bypass surgery and angioplasty patients had about the same survival rates and similar numbers of heart attacks, but that bypass surgery presents a slightly higher risk of stroke within 30 days of the procedure. A summary of the report is posted today in the online version of Annals of Internal Medicine.

"Choosing a treatment for coronary disease has long been a difficult challenge," said AHRQ Director Carolyn M. Clancy, M.D. "But this new evidence-based report provides a vital reference to help doctors, patients, and their families make the best possible decision."

Coronary artery disease, a common type of heart disease, affects about 15 million Americans and is the leading cause of death for men and women. It occurs when cholesterol and fibrous tissue clog arteries that supply blood to the heart. When arteries narrow, diminished blood flow may starve the heart muscle of oxygen and nutrients. Intense and potentially disabling chest pain, called angina, occurs when the blood supply to the heart muscle is insufficient during exercise or stress. If blood flow through a coronary artery is stopped, a heart attack -- the death of a small part of the heart muscle -- may result.

In cases where drug therapy does not adequately relieve symptoms, patients have two choices: In bypass surgery, surgeons use a blood vessel harvested from the chest, leg or arm to reroute blood flow around narrowed heart arteries. In angioplasty, a catheter is used to inflate a balloon inside the plaque-narrowed artery. A mesh tube called a stent is usually inserted to keep the artery open.

For many patients, the best treatment choice is clear. For those with most extensive disease that limits blood flow in several arteries, bypass surgery is typically used. For those with the least extensive disease, less-invasive angioplasty is the standard choice. The new federal study, funded by AHRQ's Effective Health Care program and completed by the Agency's Stanford-UCSF Evidence-based Practice Center, compared the outcomes and risks of the procedures in patients with mid-range coronary disease, where either procedure might be chosen.

Among the conclusions:

-- The odds of surviving either procedure are high: about 98.5 percent of

patients survive beyond 30 days for both bypass surgery and angioplasty

(with or without a stent).

-- Long-term survival rates are likely to be comparable. About 96 percent

of patients live at least 1 year following both procedures. About 90

percent live 5 years or more. Further research is needed to clarify

survival benefits for patients at either extreme of the mid-range


-- About 84 percent of patients who undergo bypass surgery are free of

angina pain 1 year after the procedure, compared with about 75 percent

of patients who receive angioplasty. The difference narrows but remains

substantial 5 years after treatment.

-- About 4 percent of patients who have bypass surgery undergo a repeat

procedure within 1 year, and 10 percent within 5 years. The need is

significantly higher among patients who receive angioplasty -- 24

percent more at 1 year and 33 percent more at 5 years.

-- About 0.6 percent more patients receiving bypass have a stroke during

the first 30 days after the procedure than patients receiving


-- Studies that measured patients' quality of life 6 months to 3 years

after undergoing the procedures found significantly more improvement

for bypass surgery patients than for balloon angioplasty patients. The

difference, which equalizes after 3 years, was attributed to angina


The new report, Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease, is the latest analysis from AHRQ's Effective Health Care program. That program compares alternative treatments for significant health conditions and makes the findings public. It is intended to help patients, doctors, nurses, and others choose the most effective treatments. More about the program and other reports can be found at

SOURCE Agency for Healthcare Research & Quality
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
2. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
3. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
4. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
5. ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
6. New Cardioprotective Drug Could Provide Boost For Post-Bypass Surgery Heart Health
7. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
8. Pivotal Phase III Findings With Investigational Drug Cleviprex (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
9. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
10. Cypher Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease
11. Study Shows Children With ADHD Who Start on Strattera are More Likely to Change Therapies
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Thanks to a ... Health St. Mary,s Medical Center,s Sister Diane Grassilli Center ... imaging capabilities in San Francisco . ... anonymous friend, stepped forward with a gift of $617,320 ... Breast Digital Mammography with Tomosynthesis and Whole Breast Ultrasound. ...
(Date:11/24/2015)... 2015  In the pharmaceutical industry, companies want to ... quickly uncover new insights, tactics and strategies that will ... --> However, organizations often find it is ... ensure that all rules and regulations are met to ... barrier to efficiently launching market research projects is the ...
(Date:11/24/2015)... York , 24. November 2015 /PRNewswire/ ... Avery Breathing Pacemaker Systems, ist erfreut, die ... Clinical Consultant bekannt geben zu können. ...   --> Foto - ... (Schweden). Von 1984-1986 war er ...
Breaking Medicine Technology:
(Date:11/25/2015)... Jacksonville, FL (PRWEB) , ... November 25, 2015 ... ... treatment center, is encouraging people across the country to celebrate their sobriety and ... invites people to post “before and after” photos this Thanksgiving with the hashtag ...
(Date:11/25/2015)... Lake, IL (PRWEB) , ... November 25, 2015 , ... ... to announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and ... case Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):